invasive meningococcal disease (group B)
Vaccines · 2019–2019
1decision
1medicine
1carried consumer input
201individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| meningococcal group B vaccine, multicomponent (4CMenB) Active immunisation against invasive meningococcal disease (IMD) caused by Neisseria meningitidis group B strains in individuals from 2 months of age and older. | Nov 2019 | Recommended with restriction | 201 individuals |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.